Scientific Research Grants support investigators and multidisciplinary teams conducting innovative breast cancer pilot research to advance understanding, diagnosis, treatment, and outcomes.
Funder: Florida Breast Cancer Foundation
Due Dates: December 11, 2026, 5:00 pm (LOI) | February 12, 2027, 5:00 pm (Application)
Funding Amounts: Up to $100,000 for one year, including a maximum of 20% for indirect costs
Summary: Supports innovative breast cancer pilot research with transformative potential to improve understanding, diagnosis, or treatment.
Key Information: All research activities and spending must remain in Florida, including work at collaborating entities.
The Florida Breast Cancer Foundation (FBCF) funds innovative pilot research addressing scientific and clinical breast cancer issues. The program supports basic, clinical, and translational research, including novel diagnostic and therapeutic approaches, environmental links to breast cancer in Florida, epidemiological studies, and psycho-immunologic mechanisms of disease progression.
The central goal is transformative impact on an underexplored issue of critical importance in breast cancer. Projects may address prevention, susceptibility, protection, recurrence, or metastasis, using a sound research strategy from any discipline or combination of disciplines. FBCF gives preference to new or first-time applicants and collaborative, integrated multidisciplinary research. The 2027 special emphasis areas include vulnerable populations, comorbidities and treatment-related adverse effects, novel targets, cancer immunotherapy, and genetic screening and risk assessment.